BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 3311626)

  • 1. Effectiveness of IUDs: a review.
    Sivin I; Schmidt F
    Contraception; 1987 Jul; 36(1):55-84. PubMed ID: 3311626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
    Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
    Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
    Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A
    Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of adding copper onto Lippes Loop IUDs: results from a ten-year study in Yugoslavia.
    Randic L; Haller H; Perovic M; Farr G
    Contraception; 1991 Mar; 43(3):229-39. PubMed ID: 2036794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative clinical trial of the TCu 380A, Lippes Loop D and Multiload Cu 375 IUDs in Indonesia.
    Sastrawinata S; Farr G; Prihadi SM; Hutapea H; Anwar M; Wahyudi I; Sunjoto ; Kemara KP; Champion CB; Robbins M
    Contraception; 1991 Aug; 44(2):141-54. PubMed ID: 1893708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three different models of the copper T intrauterine contraceptive device.
    Roy S; Casagrande J; Cooper DL; Mishell DR
    Am J Obstet Gynecol; 1979 Jul; 134(5):568-74. PubMed ID: 453297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.
    Sivin I; Stern J; Coutinho E; Mattos CE; el Mahgoub S; Diaz S; Pavez M; Alvarez F; Brache V; Thevenin F
    Contraception; 1991 Nov; 44(5):473-80. PubMed ID: 1797462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate postabortal insertion of intrauterine devices.
    Grimes D; Schulz K; Stanwood N
    Cochrane Database Syst Rev; 2002; (3):CD001777. PubMed ID: 12137634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five years' experience with levonorgestrel-releasing IUDs.
    Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
    Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve-month comparative multicenter study of the TCu 380A and ML 250 intrauterine devices in Bangkok, Thailand.
    Reinprayoon D; Gilmore C; Farr G; Amatya R
    Contraception; 1998 Oct; 58(4):201-6. PubMed ID: 9865999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate postabortal insertion of intrauterine devices.
    Okusanya BO; Oduwole O; Effa EE
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD001777. PubMed ID: 25101364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
    Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
    Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.